Wang, Fang <br/><br/>
miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.  [electronic resource] 

 -  Experimental & molecular medicine  May 2015 
 - e162 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2092-6413 
<br/><br/><label>Standard No.: </label>10.1038/emm.2015.17  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Cell Line, Tumor<br/>Cisplatin--therapeutic use<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lung--drug effects<br/>Lung Neoplasms--blood<br/>Male<br/>Mice<br/>Mice, Nude<br/>MicroRNAs--blood<br/>Middle Aged<br/>Prognosis<br/>Survival Analysis<br/>Treatment Outcome